Stockscreener 앱 받기
1.745
0.29%
-0.005
전일 마감가:
$1.75
열려 있는:
$1.76
하루 거래량:
86,543
Relative Volume:
0.11
시가총액:
$139.53M
수익:
$63.63M
순이익/손실:
$10.62M
주가수익비율:
34.90
EPS:
0.05
순현금흐름:
$-8.64M
1주 성능:
-1.97%
1개월 성능:
-26.68%
6개월 성능:
+14.80%
1년 성능:
+7.06%
1일 변동 폭
$1.73
$1.765
1주일 범위
$1.65
$1.81
52주 변동 폭
$1.32
$3.10
Protalix BioTherapeutics Inc. Stock (PLX) Company Profile
명칭
Protalix BioTherapeutics Inc.
전화
972 4 988 9488
주소
2 Snunit Street, Science Park PO Box 455, Karmiel
PLX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PLX
Protalix BioTherapeutics Inc.
|
1.735 | 140.74M | 63.63M | 10.62M | -8.64M | 0.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.70 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
729.43 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
462.33 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
904.45 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.81 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Protalix BioTherapeutics Inc. Stock (PLX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-06-08 | 재확인 | H.C. Wainwright | Buy |
| 2017-04-17 | 재확인 | Rodman & Renshaw | Buy |
| 2016-04-04 | 개시 | Rodman & Renshaw | Buy |
| 2015-04-23 | 업그레이드 | Jefferies | Hold → Buy |
| 2014-11-12 | 재확인 | R. F. Lafferty | Buy |
| 2014-01-24 | 개시 | R. F. Lafferty | Buy |
| 2012-05-02 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2012-05-02 | 재확인 | Oppenheimer | Outperform |
| 2012-04-30 | 다운그레이드 | Auriga | Buy → Hold |
| 2011-10-13 | 개시 | Morgan Joseph | Hold |
| 2011-03-17 | 다운그레이드 | WBB Securities | Strong Buy → Buy |
| 2010-11-09 | 재확인 | Oppenheimer | Outperform |
| 2010-10-14 | 재확인 | UBS | Buy |
| 2009-12-02 | 재확인 | Hapoalim | Outperform |
| 2009-09-22 | 개시 | Canaccord Adams | Buy |
| 2009-09-02 | 개시 | Hapoalim | Outperform |
| 2008-12-01 | 재확인 | Oppenheimer | Outperform |
| 2008-03-11 | 개시 | UBS | Buy |
| 2007-11-20 | 개시 | CIBC Wrld Mkts | Sector Outperform |
모두보기
Protalix BioTherapeutics Inc. 주식(PLX)의 최신 뉴스
Why analysts recommend Protalix BioTherapeutics Inc. (PBDA) stockJuly 2025 Selloffs & Detailed Earnings Play Strategies - Newser
Will Protalix BioTherapeutics Inc. (PBDA) stock rise with strong economy2025 Analyst Calls & Capital Protection Trading Alerts - Newser
How Protalix BioTherapeutics Inc. (DE) stock performs in volatility spikes2025 Short Interest & Growth Oriented Trading Recommendations - Newser
Why global investors buy Protalix BioTherapeutics Inc. (DE) stockMarket Sentiment Summary & Technical Entry and Exit Tips - Newser
Is Protalix BioTherapeutics Inc. (PBDA) stock a contrarian opportunity - Newser
Will Protalix BioTherapeutics Inc. (DE) stock split increase liquidityJuly 2025 Snapshot & Low Drawdown Momentum Trade Ideas - Newser
Why Protalix BioTherapeutics Inc. (DE) stock attracts wealthy investors2025 Market Trends & Scalable Portfolio Growth Methods - Newser
Is Protalix BioTherapeutics Inc. (DE) stock supported by strong fundamentals2025 Volume Leaders & Technical Confirmation Trade Alerts - Newser
How Protalix BioTherapeutics Inc. (PBDA) stock behaves under inflation pressure2025 Bull vs Bear & Verified Entry Point Detection - Newser
How Protalix BioTherapeutics Inc. (PBDA) stock compares with top peersJuly 2025 Selloffs & Short-Term High Return Ideas - Newser
Will Protalix BioTherapeutics Inc. (DE) stock test record highs in 2025Weekly Trade Recap & Risk Controlled Swing Alerts - Newser
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Sentiment Watch: Is Protalix BioTherapeutics Inc. stock attractive for hedge fundsCPI Data & AI Based Buy and Sell Signals - BỘ NỘI VỤ
Protalix BioTherapeutics Inc. R (PBDA.F) Q1 FY2025 earnings call transcript - Yahoo Finance
Protalix BioTherapeutics Inc. R (PBDA.F) Q2 FY2025 earnings call transcript - Yahoo Finance
Research Analysts Set Expectations for PLX FY2025 Earnings - Defense World
HC Wainwright Lowers Protalix BioTherapeutics (NYSE:PLX) Price Target to $12.00 - Defense World
PLX Analyst Forecasts - Quiver Quantitative
Protalix BioTherapeutics (PLX) Price Target Lowered by HC Wainwr - GuruFocus
HC Wainwright & Co. Maintains Protalix BioTherapeutics (PLX) Buy Recommendation - Nasdaq
Can Protalix BioTherapeutics Inc. (PBDA) stock sustain double digit ROEJuly 2025 Pullbacks & Weekly High Conviction Trade Ideas - newser.com
Is Protalix BioTherapeutics Inc. stock undervalued vs historical averagesQuarterly Profit Summary & Long Hold Capital Preservation Tips - newser.com
What RSI levels show for Protalix BioTherapeutics Inc. (PBDA) stockJuly 2025 Fed Impact & Advanced Technical Signal Analysis - newser.com
Zacks Small Cap Has Bearish Outlook for PLX FY2025 Earnings - Defense World
Will Protalix BioTherapeutics Inc. stock maintain dividend yieldJuly 2025 Decliners & Daily Entry Point Alerts - newser.com
PLX: Protalix Seeks Re-Examination of CHMP Opinion - MSN
How to integrate Protalix BioTherapeutics Inc. into portfolio analysis toolsEarnings Summary Report & Safe Capital Growth Stock Tips - newser.com
[Form 4] Protalix BioTherapeutics, Inc. Insider Trading Activity - Stock Titan
Real time scanner hits for Protalix BioTherapeutics Inc. explained2025 Stock Rankings & Safe Entry Trade Reports - newser.com
Will breakout in Protalix BioTherapeutics Inc. lead to full recovery2025 Major Catalysts & Real-Time Price Movement Reports - newser.com
How Protalix BioTherapeutics Inc. stock reacts to job market dataWeekly Gains Summary & Detailed Earnings Play Strategies - newser.com
A History of Outperforming Analyst Forecasts and Beating the Odds: Protalix BioTherapeutics Inc (PLX) - Setenews
Will Protalix BioTherapeutics Inc. stock benefit from AI adoptionDip Buying & Verified Momentum Stock Watchlist - newser.com
Protalix BioTherapeutics Inc. (PLX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.29%
0.67%
자본화:
|
볼륨(24시간):